Prosecution Insights
Last updated: April 19, 2026

Asklepios Biopharmaceutical Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17913728 FORSKOLIN-INDUCIBLE PROMOTERS AND HYPOXIA-INDUCIBLE PROMOTERS BRETZ, COREY LANE 1635 Non-Final OA Sep 22, 2022
17793196 RECOMBINANT AAV PRODUCTION GODDARD, LAURA B 1642 Final Rejection Jul 15, 2022

Managing Asklepios Biopharmaceutical Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month